ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Medical Director at Veracyte - ApplyBlast

Medical Director

Veracyte

6 days ago

3.6 on Glassdoor

Remote

Full Time

Director

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Medical Director establishes and implements the medical affairs strategy for the Afirma/endocrinology franchise to advance genomic products into clinical practice. The role involves developing key opinion leader relationships, executing publication strategies, providing scientific support to the commercial team, and leading R&D and clinical trial strategy. This position requires extensive expertise in scientific writing, clinical research, and cross-functional collaboration to drive product adoption and reimbursement.

Responsibilities

Establish and implement medical affairs strategy for the Afirma/endocrinology franchise
Develop and execute publication plans to support product adoption and reimbursement
Lead scientific support for commercial teams and R&D clinical trial strategy

Skills

Qualifications

PhDMD

About Veracyte

veracyte.com

Headquarters

South San Francisco, California, United States

Company Size

501-1000 employees

Founded

2008

View Profile

Veracyte is a genomic diagnostics company that develops and delivers molecular tests to provide clinicians with actionable molecular insights for cancer care. Their high‑performing tests support patient management across thyroid, prostate, bladder, breast, and lung cancers, helping physicians give patients informed answers now and tailor personalized treatment plans. Veracyte focuses on translating genomic data into clinically useful results to improve diagnostic accuracy and guide therapy decisions. Their mission—"Exceptional cancer care begins with exceptional diagnostics"—reflects a commitment to advancing precision oncology and better patient outcomes.